Cutler Group’s VivoSim Labs VIVS Stock Holding History

Cutler Group’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-41	Closed	-$1K	–	7378
2016 Q4	$1K	Sell	41 -54	-57%	-$42.9K	﹤0.01%	6209
2016 Q3	$6K	Buy	95 +60	+171%	+$58.7K	﹤0.01%	4829
2016 Q2	$5K	Buy	+35	New	+$23.5K	﹤0.01%	4998

Other funds holding VIVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cutler Group's VIVS Position: Q2 2017 in Review

Cutler Group sold out of VivoSim Labs (VIVS) in Q2 2017, closing a stake of 122 shares — an estimated $82K sold.

Cutler Group first reported a position in VIVS in Q4 2015 and held it in 6 quarters. The position peaked at $130K in Q3 2016. 117 funds tracked by Wall St. Rank hold VIVS as of Q2 2017.

Cutler Group reported no remaining VivoSim Labs position as of Q2 2017 after selling out during the quarter.
Cutler Group sold 122 VivoSim Labs shares in Q2 2017, an estimated $82K.
Cutler Group first reported a position in VivoSim Labs in Q4 2015 and held it in 6 quarters.
Cutler Group's VivoSim Labs position peaked at $130K in Q3 2016.
117 funds tracked by Wall St. Rank held VivoSim Labs as of Q2 2017.

Based on Cutler Group's 13F filing for Q2 2017, filed 11 Jul 2017.